"Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital, in South Weymouth, MA, provides residents south of Boston with the highest level of cancer care in the region. Experts from Dana-Farber Cancer Institute, Brigham and Women's Hospital, and South Shore Hospital collaborate to offer locally many of the advanced treatments currently offered at Dana-Farber/Brigham and Women's Cancer Center in Boston, including clinical trials exploring new therapies. We can provide a smooth transition to Dana-Farber/Brigham and Women's Cancer Center in Boston for patients who require care from our physicians with expertise in specific disease areas."

During the past decade, Dana-Farber/Brigham and Women's Cancer Center at South Shore conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 16 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 13 clinical trials were completed. i.e. 216.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dana-Farber/Brigham and Women's Cancer Center at South Shore" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 13 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dana-Farber/Brigham and Women's Cancer Center at South Shore" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Dana-Farber/Brigham and Women's Cancer Center at South Shore" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "HER2/Neu Negative" (3 trials), "Invasive Breast Carcinoma" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Dana-Farber/Brigham and Women's Cancer Center at South Shore" in a lesser frequency.

Most popular intervention types in "Dana-Farber/Brigham and Women's Cancer Center at South Shore" are "Other" (25 trials), "Drug" (24 trials), "Radiation" (10 trials), "Biological" (9 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Quality-of-Life Assessment" (9 trials), "Paclitaxel" (6 trials), "Carboplatin" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Dana-Farber/Brigham and Women's Cancer Center at South Shore" are 24 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Dana-Farber/Brigham and Women's Cancer Center at South Shore". undefined are not yet recruiting, 9 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Dana-Farber/Brigham and Women's Cancer Center at South Shore, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dana-Farber/Brigham and Women's Cancer Center at South Shore, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".